{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:42:24Z","timestamp":1760182944071,"version":"build-2065373602"},"reference-count":121,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.rdc.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T06:58:26Z","timestamp":1339311506000},"page":"355-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"38","author":[{"given":"Katherine Anne B.","family":"Marzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bracha","family":"Shaham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2012.04.006_bib1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib2","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib3","first-page":"366","article-title":"Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy","volume":"25","author":"Flato","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib4","first-page":"579","article-title":"Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup","volume":"30","author":"Fantini","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2012.04.006_bib5","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1002\/art.22181","article-title":"Long-term outcome and prognostic factors in enthesitis-related arthritis: a case control study","volume":"54","author":"Flat\u00f8","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2012.04.006_bib6","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/art.21389","article-title":"Patterns of clinical remission in select\u00a0categories of juvenile idiopathic arthritis","volume":"52","author":"Wallace","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/ard.2007.078121","article-title":"A\u00a0longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis","volume":"67","author":"Magni-Manzoni","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2012.04.006_bib8","first-page":"20","article-title":"Adult outcomes of patients with juvenile idiopathic arthritis","volume":"72","author":"Minden","year":"2009","journal-title":"Horm Res"},{"issue":"9","key":"10.1016\/j.rdc.2012.04.006_bib9","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib10","series-title":"Conn\u2019s current therapy\u20142006","first-page":"1188","article-title":"Treatment update on juvenile arthritis","author":"Reiff","year":"2006"},{"issue":"3","key":"10.1016\/j.rdc.2012.04.006_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/art.20963","article-title":"A\u00a0two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis","volume":"52","author":"Lien","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0889-857X(21)00134-4","article-title":"Juvenile rheumatoid arthritis: outcome and treatment for the 1990s","volume":"17","author":"Wallace","year":"1991","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 330","key":"10.1016\/j.rdc.2012.04.006_bib13","first-page":"6","article-title":"Dismantling the pyramid","volume":"19","author":"Levinson","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2012.04.006_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.21174","article-title":"Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis","volume":"53","author":"Stone","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2012.04.006_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3899\/jrheum.080560","article-title":"Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis","volume":"36","author":"Magnani","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/ard.2007.073445","article-title":"The magnitude of early response to methotrexate therapy predicts long-term outcomes of patients with juvenile idiopathic arthritis","volume":"67","author":"Bartoli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.1790080109","article-title":"Predicting pain among children with juvenile rheumatoid arthritis","volume":"8","author":"Hagglund","year":"1995","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/adc.77.5.451","article-title":"How painful is juvenile chronic arthritis?","volume":"77","author":"Kuis","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rdc.2012.04.006_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/03009749709105316","article-title":"Cold pressor pain: comparing responses of juvenile arthritis patients and their parents","volume":"26","author":"Thastum","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib20","first-page":"545","article-title":"Juvenile chronic arthritis with persistently positive tests for rheumatoid factor (sero-positive juvenile rheumatoid arthritis)","volume":"30","author":"Ansell","year":"1983","journal-title":"Ann Pediatr (Paris)"},{"key":"10.1016\/j.rdc.2012.04.006_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3476(67)80259-2","article-title":"Monarticular juvenile rheumatoid arthritis","volume":"70","author":"Cassidy","year":"1967","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib22","first-page":"30","article-title":"Pauciarticular juvenile rheumatoid arthritis","volume":"12","author":"Schaller","year":"1969","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib23","first-page":"1531","article-title":"Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis","volume":"29","author":"Huemer","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib24","first-page":"166","article-title":"Torticollis as the sole initial presenting sign of systemic onset juvenile rheumatoid arthritis","volume":"25","author":"Uziel","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.49.8.620","article-title":"Middle ear function in patients with juvenile chronic arthritis","volume":"49","author":"Siamopoulou-Mavridou","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib26","first-page":"952","article-title":"Stridor due to cricoarytenoid arthritis in pauciarticular onset juvenile rheumatoid arthritis","volume":"13","author":"Malleson","year":"1986","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib27","first-page":"71","article-title":"Craniomandibular function in juvenile chronic arthritis: a clinical and radiographic study","volume":"15","author":"Olson","year":"1991","journal-title":"Swed Dent J"},{"key":"10.1016\/j.rdc.2012.04.006_bib28","first-page":"1956","article-title":"Temporomandibular joint and mandibular growth alterations in patients with juvenile rheumatoid arthritis","volume":"22","author":"Ronchezel","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2012.04.006_bib29","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B","article-title":"Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids","volume":"42","author":"Sherry","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib30","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)","volume":"35","author":"Beherens","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0950-3579(98)80018-6","article-title":"Systemic onset juvenile rheumatoid arthritis","volume":"12","author":"Schneider","year":"1998","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnosis guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.21039","article-title":"HLH -2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rdc.2012.04.006_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.88.3.186","article-title":"Biologic therapies for juvenile arthritis","volume":"88","author":"Wilkinson","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rdc.2012.04.006_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17 producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib36","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/rheumatology\/keq130","article-title":"Treating arthritis by immunomodulation: is there a role for immunomodulatory T cells?","volume":"49","author":"Wehrens","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2012.04.006_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.berh.2009.07.003","article-title":"Using biology of disease to understand and guide therapy of JIA","volume":"23","author":"Prakken","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s100670200012","article-title":"Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis","volume":"21","author":"Ou","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis. Report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11926-005-0047-2","article-title":"The use of anakinra in juvenile arthritis","volume":"7","author":"Reiff","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2012.04.006_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/CRIAI:28:3:231","article-title":"Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis","volume":"28","author":"Yokota","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rdc.2012.04.006_bib42","doi-asserted-by":"crossref","first-page":"001","DOI":"10.1007\/s13554-012-0001-6","article-title":"Treatment of systemic juvenile idiopathic arthritis with tocilizumab\u2014the role of anti-interleukin-6 therapy after a decade of treatment","volume":"2","author":"Reiff","year":"2012","journal-title":"Biol Ther"},{"key":"10.1016\/j.rdc.2012.04.006_bib43","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2010.148635","article-title":"Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups","volume":"70","author":"Finnegan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2012.04.006_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/art.30076","article-title":"Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis","volume":"63","author":"Ravelli","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib46","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","article-title":"Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis","volume":"61","author":"Avcin","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib47","first-page":"1382","article-title":"Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study","volume":"33","author":"Selvaag","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s100670050156","article-title":"Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study","volume":"19","author":"Periloux","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2431-4-13","article-title":"Clinical utility of antibody tests in children","volume":"4","author":"McGhee","year":"2004","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib50","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3899\/jrheum.081156","article-title":"Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis","volume":"36","author":"Masi","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib51","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00247-010-1897-y","article-title":"Differences in MRI findings between subgroups of recent-onset childhood arthritis","volume":"41","author":"Kirkhus","year":"2011","journal-title":"Pediatr Radiol"},{"issue":"11","key":"10.1016\/j.rdc.2012.04.006_bib54","first-page":"2337","article-title":"Magnetic resonance imaging identifies features in clinically unaffected knees predicting extension of arthritis in children with monoarthritis","volume":"33","author":"Gardner-Medwin","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2012.04.006_bib55","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.24313","article-title":"Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis","volume":"59","author":"Malattia","year":"2008","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.rdc.2012.04.006_bib56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1442-200X.2009.02873.x","article-title":"Early diagnosis for polyarthritis of juvenile idiopathic arthritis using systemic gallium scintigraphy","volume":"51","author":"Yamazaki","year":"2009","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rdc.2012.04.006_bib57","first-page":"774","article-title":"Ultrasound detection of heel enthesitis: a comparison with magnetic resonance imaging","volume":"30","author":"Kamel","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2012.04.006_bib58","first-page":"13","article-title":"Natural history of growth and body composition in juvenile idiopathic arthritis","volume":"72","author":"Bechtold","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib59","series-title":"Textbook of pediatric rheumatology","first-page":"211","article-title":"Chronic arthritis in childhood","author":"Petty","year":"2010"},{"key":"10.1016\/j.rdc.2012.04.006_bib60","first-page":"2214","article-title":"Frequency of abnormal hand and wrist radiographs at time of diagnosis of polyarticular juvenile rheumatoid arthritis","volume":"29","author":"Mason","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib61","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.100090","article-title":"Early predictors of juvenile sacroiliitis in enthesitis-related arthritis","volume":"37","author":"Pagnini","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib62","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/art.11097","article-title":"Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis. A long-term outcome study of one hundred five patients","volume":"48","author":"Lien","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2012.04.006_bib63","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1359\/JBMR.040805","article-title":"Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones","volume":"19","author":"M\u00e5rtensson","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.rdc.2012.04.006_bib64","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/acr.20613","article-title":"Changes in vascular function and\u00a0structure in juvenile idiopathic arthritis","volume":"63","author":"Vlahos","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib65","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21774","article-title":"Predictors of disease course and remission in systemic juvenile idiopathic arthritis","volume":"54","author":"Singh-Grewal","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib66","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","article-title":"Early predictors of poor functional outcome in systemic onset juvenile rheumatoid arthritis: a multicenter cohort study","volume":"43","author":"Spiegel","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(05)80427-5","article-title":"Prognostic indicators of joint destruction in systemic juvenile rheumatoid arthritis","volume":"12","author":"Schneider","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.rdc.2012.04.006_bib68","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.24539","article-title":"Predictors of early inactive disease in juvenile idiopathic arthritis: results of a Canadian mulitcenter, prospective inception cohort study","volume":"61","author":"Oen","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib69","first-page":"386","article-title":"Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years","volume":"30","author":"Flato","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib70","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3899\/jrheum.080543","article-title":"Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis","volume":"36","author":"Flato","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib71","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3899\/jrheum.100014","article-title":"Spondyloarthritis in a pediatric population: risk factors for sacroiliitis","volume":"37","author":"Stoll","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib72","first-page":"722","article-title":"Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials","volume":"33","author":"Chen","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.2006.054098","article-title":"No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open label trial","volume":"66","author":"Haibel","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.berh.2005.11.008","article-title":"Current management of juvenile idiopathic arthritis","volume":"20","author":"Wallace","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib75","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/ard.2006.064717","article-title":"Long-term outcome\u00a0of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment","volume":"66","author":"van Rossum","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"10.1016\/j.rdc.2012.04.006_bib76","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The pediatric rheumatology collaborative study group and the cooperative children\u2019s study group","volume":"326","author":"Giannini","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2012.04.006_bib77","first-page":"1830","article-title":"Methotrexate in juvenile idiopathic arthritis: answers and questions","volume":"27","author":"Ravelli","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2012.04.006_bib78","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A\u00a0randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2012.04.006_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(95)70320-9","article-title":"Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth","volume":"127","author":"Huppertz","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib81","first-page":"2100","article-title":"Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis","volume":"28","author":"Ravelli","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib82","first-page":"2507","article-title":"Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis","volume":"31","author":"Eberhard","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib83","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","article-title":"Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2012.04.006_bib84","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.24190","article-title":"Optimal treatment of knee monoarthritis in juvenile idiopathic arthritis: a decision analysis","volume":"59","author":"Beukelman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib85","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00431-007-0525-9","article-title":"Factor influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis","volume":"167","author":"Marti","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib86","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis","volume":"342","author":"Lovell","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2012.04.006_bib87","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","article-title":"Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib88","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/rheumatology\/kep122","article-title":"Safety and efficacy of once weekly etanercept 0.8 mg\/kg in a multicentre, 12 week trial in active polyarticular course juvenile idiopathic arthritis","volume":"48","author":"Horneff","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2012.04.006_bib89","first-page":"2481","article-title":"Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis","volume":"34","author":"Vojvodich","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib90","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/art.27682","article-title":"Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis","volume":"62","author":"Giannini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib91","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/art.20793","article-title":"Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor \u03b1 monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis","volume":"52","author":"Gerloni","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib92","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.2009.100354","article-title":"Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension","volume":"69","author":"Ruperto","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.4.5.549","article-title":"Adalimumab in juvenile rheumatoid arthritis\/juvenile idiopathic arthritis","volume":"4","author":"Marzan","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rdc.2012.04.006_bib94","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.rdc.2004.02.004","article-title":"Adalimumab therapy in rheumatoid arthritis","volume":"30","author":"Keystone","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2012.04.006_bib95","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0149-2918(03)80164-9","article-title":"Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study","volume":"25","author":"Weisman","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.rdc.2012.04.006_bib96","unstructured":"Humira\u00ae (adalimumab). [package insert]. North Chicago (IL): Abbott Laboratories; 2011."},{"key":"10.1016\/j.rdc.2012.04.006_bib97","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2012.04.006_bib98","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10067-009-1162-7","article-title":"Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and\/or infliximab","volume":"28","author":"Katsicas","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/03009742.2010.517546","article-title":"Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis","volume":"40","author":"Trachana","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","article-title":"Adalimumab therapy for childhood uveitis","volume":"149","author":"Vazquez-Cobian","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.rdc.2012.04.006_bib101","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","article-title":"Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2012.04.006_bib103","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/acr.20283","article-title":"Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2012.04.006_bib104","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.rdc.2012.04.006_bib105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.090952","article-title":"Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents","volume":"36","author":"Russo","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib106","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib107","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib108","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","article-title":"A\u00a0phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features","volume":"64","author":"Ruperto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.rdc.2012.04.006_bib109","first-page":"S496","article-title":"Preliminary data from a study of Kineret TM (anakinra) in children with juvenile rheumatoid arthritis","volume":"46","author":"Reiff","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A\u00a0multicentre, randomised, double-blind, placebo controlled trial with interleukin-1 receptor antagonist anakinra in patients with systemic onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib111","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The patterns of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-008-0995-9","article-title":"Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study","volume":"28","author":"Ilowite","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2012.04.006_bib113","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2012.04.006_bib114","article-title":"Tocilizumab is efficacious in patients with systemic juvenile idiopathic arthritis across baseline demographic and disease characteristics and prior\/baseline treatments: 52 week data from a phase 3 clinical trial","volume":"63","author":"De Benedetti","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2012.04.006_bib115","article-title":"Efficacy and safety of tocilizumab in patients with systemic juvenile idiopathic arthritis: 2 year data from a phase III clinical trial","volume":"63","author":"De Benedetti","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2012.04.006_bib116","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"Woo","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2012.04.006_bib117","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomized, double- blind, placebo- controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2012.04.006_bib118","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/ard.2010.145359","article-title":"Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment","volume":"70","author":"Inaba","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2012.04.006_bib119","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of combination etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA registry","volume":"68","author":"Horneff","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2012.04.006_bib120","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","article-title":"Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomized open-label clinical trial","volume":"70","author":"Tynj\u00e4l\u00e4","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2012.04.006_bib121","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X12000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:12:12Z","timestamp":1760181132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X12000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0889857X12000373"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2012.04.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2012.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}